Related Experiment Videos
[Complications caused by protamine. 2. Therapy and prevention]
J Hobbhahn1, H Habazettl, P Conzen
1Institut für Anaesthesiologie der Ludwig-Maximilians-Universität München, Klinikum Grosshadern.
Der Anaesthesist
|August 1, 1991
Summary
Symptomatic treatment is key for protamine reactions, focusing on hypotension and right ventricular dysfunction. Prevention strategies are limited, with no reliable tests for identifying at-risk patients before procedures.
Area of Science:
- Pharmacology and Toxicology
- Cardiovascular Medicine
- Anaphylaxis Research
Context:
- Protamine sulfate is crucial for reversing heparin anticoagulation but can cause severe anaphylactic/anaphylactoid reactions.
- These reactions present as hypotension, vasodilation, and right ventricular dysfunction, complicating surgical procedures.
- Current treatment and prevention strategies for protamine reactions are limited and often ineffective.
Purpose:
- To review and summarize current approaches to treating and preventing protamine-induced anaphylactic/anaphylactoid reactions.
- To evaluate the efficacy of various symptomatic treatments and prophylactic measures.
- To identify potential future therapeutic targets for preventing these adverse events.
Summary:
- Treatment of protamine reactions is symptomatic, addressing hypotension with volume infusion and catecholamines, and improving coronary perfusion in cases of right ventricular dysfunction.
- Prevention is challenging due to the lack of reliable diagnostic tests for identifying susceptible individuals; slow protamine infusion and avoiding hypovolemia are recommended.
- General prophylaxis with H1/H2 antagonists is not justified, and while alternatives like prostacyclin or hexadimethrine exist, their use is situational. Thromboxane receptor antagonists show future promise.
Impact:
- Highlights the limitations of current protamine reaction management, emphasizing symptomatic care over prophylaxis.
- Informs clinical practice regarding the cautious use of protamine and the limited options for prevention.
- Suggests future research directions, particularly in pharmacologic prevention targeting pathways like thromboxane.